Table 4.
Results on visits and days until final diagnosis in both study arms.
| Diagnosis | Control arm | Intervention arm | p-value |
|---|---|---|---|
| Diagnosis at initial visit | n = 262 | n = 264 | 0.39 |
| Benign/negative | 149/262 (60.7%) | 146/264 (55.3%) | |
| Malignant | 87/262 (33.2%) | 99/264 (37.5%) | |
| Inconclusive and follow-up required | 26/262 (6.1%) | 19/264 (7.2%) | |
| Days until diagnosis | n = 262 | n = 264 | |
| Median | 1 | 1 | 0.17a |
| IQR | 0–4 | 0–3 | |
| Range | 0–748 | 0–653 | |
| Category | |||
| 0 days | 37.8% (99/262) | 40.5% (107/264) | |
| 1–5 days | 45.4% (119/262) | 45.8% (121/264) | |
| 6–14 days | 6.1% (16/262) | 5.7% (15/264) | |
| 15–180 days | 5.3% (14/262) | 3.4% (9/264) | |
| 181–365 days | 3.4% (9/262 | 3.4% (9/264) | |
| >365 days | 1.9% (5/262) | 1.1% (3/264) |
Abbreviations – IQR: interquartile range.
p-value from Mann–Whitney U test.